Improved one-year survival after acute myocardial infarction in Iceland between 1986 and 1996

Cardiology

Volumn 91, Issue 3, 1999, Pages 210-214

  Kristjansson, Jon M ^a   Andersen, Karl ^b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b Reykjavik City Hospital   (Iceland)

Author keywords

Acute myocardial infarction; Mortality; Prognosis; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIURETIC AGENT; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; ICELAND; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

AGED; FEMALE; HUMANS; ICELAND; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY;

EID: 0032877856     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000006912     Document Type: Article

References (16)

1. Second International Study on Infarct Survival Collaborative Group: Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected myocardial infarction: ISIS-2. Lancet 1988;ii:349-360.
2. The RISC Group: Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336:827-830.
3. The MIAMI Trial Research Group: Metoprolol in acute myocardial infarction (MIAMI). Eur Heart J 1985;5199-5226.
4. First International Study on Infarct Survival Collaborative Group: Radomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986;ii:257-266.
5. Gruppo Italiani per lo Studio della Streptochinase nell 'Infarcto Myocardico (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;ii: 1397-1401.
6. The GUSTO Investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682.
7. CONSENSUS Trial Study Group: Effect of enalapril on mortality in severe congestive heart failure: Results of the cooperative North-Scandinavian enalapril survival study (CONSENSUS). N Engl J Med 1987;316:678-684.
8. McKelvie R, McConachie D, Yusuf S: Role of angiotensin converting enzyme inhibitors in patients with left ventricular dysfunction and congestive heart failure. Eur Heart J 1994; 15(suppl B):9-13.
9. The Acute Infarction Ramipril Efficacy (AIRE) study investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:28.
10. The 4S Investigators: Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344: 1383-1389.
11. McGovern PG, Herlitz J, Pankoe JS, Karlsson T, Dellborg M, Shahar E, Luepker RV: Comparison of medical care and 12-month mortality of hospitalised patients with acute myocardial infarction in Minneapolis-St. Paul, Minnesota, USA and Göteborg, Sweden. Am J Cardiol 1997;80:557-562.
12. Sigfusson N, Sigvaldason H, Steingrimsdottir L, Gudmundsdotlir II, Stefansdottir I, Thorsteinsson TH, Sigurdsson G: Decline in ischemic heart disease in Iceland and change in risk factor levels. BMJ 1991;302:1371-1375.
13. Madsen JK, Pedersen F, Nielsen H, Jensen GV, Hansen JF: Improvement of long-term prognosis in elderly patients with acute myocardial infarction after the introduction of intravenous thrombolytic therapy. Scand Cardiovasc J 1998;32:365-370.
14. Herlitz J, Hartford M, Karlson BW, Dellborg M, Källström G, Karlsson T: One-year mortality after acute myocardial infarction prior to and after the implementation of a widespread use of thrombolysis and aspirin. Cardiology 1998;89:216-221.
15. Gottlieb SS, McCarter RJ, Vogel RA: Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998;339:489-497.
16. Buring JE, Glynn RJ, Hennekens CH: Calcium channel blockers and acute myocardial infarction: A hypothesis formulated but not yet tested. JAMA 1995;274:5.